- Home
- CRGY vs STAA Comparison
CRGY vs STAA Comparison
Compare CRGY & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGY | STAA |
|---|---|---|
| Founded | 1986 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Ophthalmic Goods |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 867.9M |
| IPO Year | 2022 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CRGY | STAA |
|---|---|---|
| Price | $13.69 | $17.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 9 |
| Target Price | $14.00 | ★ $22.19 |
| AVG Volume (30 Days) | ★ 9.8M | 1.2M |
| Earning Date | 05-04-2026 | 03-03-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,579,782,000.00 | $239,442,000.00 |
| Revenue This Year | $27.35 | $27.04 |
| Revenue Next Year | N/A | $7.27 |
| P/E Ratio | $99.08 | ★ N/A |
| Revenue Growth | ★ 22.14 | N/A |
| 52 Week Low | $6.83 | $14.69 |
| 52 Week High | $13.86 | $30.81 |
Technical Indicators
Market Signals| Indicator | CRGY | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 73.58 | 45.83 |
| Support Level | $8.19 | $17.13 |
| Resistance Level | N/A | $18.01 |
| Average True Range (ATR) | 0.46 | 0.98 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 86.01 | 42.49 |
Price Performance
Historical ComparisonAbout CRGY Crescent Energy Company
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The Company's investing and operating activities are focused in Texas and the Rocky Mountain region.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.